AI Engines For more Details: Perplexity Kagi Labs You
Hypercholesterolemia:
Coronary Heart Disease (CHD):
Prevention of Cardiovascular Events:
Stroke Prevention:
Peripheral Arterial Disease (PAD):
Side Effects:
Monitoring:
Lifestyle Modifications:
| Rank | Probiotic | Impact |
|---|---|---|
| genus | Bifidobacterium | Reduces |
| species | Bacillus subtilis | Reduces |
| species | Bacteroides uniformis | Reduces |
| species | Bifidobacterium adolescentis | Reduces |
| species | Bifidobacterium longum | Reduces |
| species | Escherichia coli | Reduces |
| species | Lacticaseibacillus paracasei | Reduces |
| species | Parabacteroides distasonis | Reduces |
| subspecies | Bacillus subtilis subsp. natto | Reduces |
| subspecies | Bifidobacterium longum subsp. infantis | Reduces |
| subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.5 | 0.5 | |
| Acne | 0.6 | 0.9 | -0.5 |
| ADHD | 4.5 | 0.9 | 4 |
| Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
| Allergic Rhinitis (Hay Fever) | 3.3 | 2.8 | 0.18 |
| Allergies | 6.5 | 2.9 | 1.24 |
| Allergy to milk products | 2 | 1.6 | 0.25 |
| Alopecia (Hair Loss) | 1.6 | 1.6 | |
| Alzheimer's disease | 4.7 | 7.1 | -0.51 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.4 | 0.9 | 1.67 |
| Ankylosing spondylitis | 4.9 | 1.3 | 2.77 |
| Anorexia Nervosa | 2.1 | 2.9 | -0.38 |
| Antiphospholipid syndrome (APS) | 1.7 | 0.3 | 4.67 |
| Asthma | 4.6 | 2.3 | 1 |
| Atherosclerosis | 2 | 2 | 0 |
| Atrial fibrillation | 3.7 | 3.2 | 0.16 |
| Autism | 8.5 | 9 | -0.06 |
| Autoimmune Disease | 1.2 | 1 | 0.2 |
| Barrett esophagus cancer | 0.3 | 0.3 | 0 |
| benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
| Biofilm | 2.7 | 2.7 | |
| Bipolar Disorder | 2.4 | 1.7 | 0.41 |
| Brain Trauma | 0.9 | 1.4 | -0.56 |
| Breast Cancer | 0.6 | 0.6 | |
| Cancer (General) | 0.6 | 2.8 | -3.67 |
| Carcinoma | 4.3 | 2.9 | 0.48 |
| Celiac Disease | 2.6 | 3.9 | -0.5 |
| Cerebral Palsy | 1.4 | 1.3 | 0.08 |
| Chronic Fatigue Syndrome | 4.5 | 6.5 | -0.44 |
| Chronic Kidney Disease | 4.7 | 2.9 | 0.62 |
| Chronic Lyme | 0.6 | 0.8 | -0.33 |
| Chronic Obstructive Pulmonary Disease (COPD) | 2.1 | 1.7 | 0.24 |
| Chronic Urticaria (Hives) | 2 | 0.9 | 1.22 |
| Coagulation / Micro clot triggering bacteria | 1.9 | 1.3 | 0.46 |
| Cognitive Function | 3.2 | 1.6 | 1 |
| Colorectal Cancer | 6.6 | 2.5 | 1.64 |
| Constipation | 1.5 | 0.7 | 1.14 |
| Coronary artery disease | 2.8 | 2.7 | 0.04 |
| COVID-19 | 8 | 9.4 | -0.18 |
| Crohn's Disease | 7.6 | 5 | 0.52 |
| Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
| cystic fibrosis | 1.2 | 1.9 | -0.58 |
| d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
| deep vein thrombosis | 2.7 | 1.4 | 0.93 |
| Denture Wearers Oral Shifts | 0.5 | 0.5 | |
| Depression | 9.4 | 8.8 | 0.07 |
| Dermatomyositis | 0.3 | 0.3 | 0 |
| Eczema | 1.8 | 1.6 | 0.13 |
| Endometriosis | 3.8 | 2.6 | 0.46 |
| Eosinophilic Esophagitis | 0.6 | -0.6 | |
| Epilepsy | 3.2 | 1.7 | 0.88 |
| erectile dysfunction | 1.5 | 0.3 | 4 |
| Fibromyalgia | 3.1 | 2.1 | 0.48 |
| Functional constipation / chronic idiopathic constipation | 6.4 | 4.3 | 0.49 |
| gallstone disease (gsd) | 3.8 | 0.8 | 3.75 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 1 | -0.67 |
| Generalized anxiety disorder | 2.9 | 2.4 | 0.21 |
| giant cell arteritis | 0.2 | -0.2 | |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 1.8 | 0.8 | 1.25 |
| Graves' disease | 1.9 | 3.3 | -0.74 |
| Gulf War Syndrome | 0.9 | 0.8 | 0.13 |
| Halitosis | 0.9 | 0.3 | 2 |
| Hashimoto's thyroiditis | 3.3 | 1.8 | 0.83 |
| Heart Failure | 4.2 | 1.9 | 1.21 |
| hemorrhagic stroke | 1 | 1 | |
| Hidradenitis Suppurativa | 1.2 | 0.3 | 3 |
| High Histamine/low DAO | 1.8 | 0.6 | 2 |
| hypercholesterolemia (High Cholesterol) | 1.1 | 1.1 | |
| hyperglycemia | 1.4 | 1.1 | 0.27 |
| Hyperlipidemia (High Blood Fats) | 0.9 | 0.3 | 2 |
| hypersomnia | 0.7 | -0.7 | |
| hypertension (High Blood Pressure | 4.7 | 4.5 | 0.04 |
| Hypothyroidism | 1 | -1 | |
| Hypoxia | 3.4 | 1 | 2.4 |
| IgA nephropathy (IgAN) | 1.6 | 3.8 | -1.37 |
| Inflammatory Bowel Disease | 6.4 | 10.1 | -0.58 |
| Insomnia | 1.9 | 2.4 | -0.26 |
| Intelligence | 1.4 | 0.7 | 1 |
| Intracranial aneurysms | 1.2 | 0.9 | 0.33 |
| Irritable Bowel Syndrome | 7.4 | 4.7 | 0.57 |
| ischemic stroke | 3.1 | 1.7 | 0.82 |
| Liver Cirrhosis | 6.9 | 4 | 0.73 |
| Long COVID | 5.6 | 6.8 | -0.21 |
| Low bone mineral density | 1.1 | -1.1 | |
| Lung Cancer | 1.2 | 1 | 0.2 |
| Lymphoma | 0.6 | 0.6 | |
| Mast Cell Issues / mastitis | 0.9 | 0.9 | 0 |
| ME/CFS with IBS | 0.8 | 1.8 | -1.25 |
| ME/CFS without IBS | 1.3 | 2.2 | -0.69 |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 2 | 0.5 | 3 |
| Metabolic Syndrome | 8.2 | 6.4 | 0.28 |
| Mood Disorders | 9.2 | 7.8 | 0.18 |
| multiple chemical sensitivity [MCS] | 0.6 | 0.1 | 5 |
| Multiple Sclerosis | 6.4 | 5.9 | 0.08 |
| Multiple system atrophy (MSA) | 0.7 | 0.7 | 0 |
| myasthenia gravis | 0.9 | 0.7 | 0.29 |
| neuropathic pain | 0.3 | 2.6 | -7.67 |
| Neuropathy (all types) | 0.7 | 2.9 | -3.14 |
| neuropsychiatric disorders (PANDAS, PANS) | 1.2 | 1.2 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 5.7 | 4.3 | 0.33 |
| NonCeliac Gluten Sensitivity | 1.3 | 0.6 | 1.17 |
| Obesity | 10.8 | 7.2 | 0.5 |
| obsessive-compulsive disorder | 4.8 | 4.7 | 0.02 |
| Osteoarthritis | 2 | 1.2 | 0.67 |
| Osteoporosis | 3 | 1.3 | 1.31 |
| pancreatic cancer | 0.6 | 0.3 | 1 |
| Parkinson's Disease | 7.6 | 6.6 | 0.15 |
| Polycystic ovary syndrome | 5.7 | 2.9 | 0.97 |
| Postural orthostatic tachycardia syndrome | 0.2 | 0.6 | -2 |
| Premenstrual dysphoric disorder | 0.7 | 0.4 | 0.75 |
| primary biliary cholangitis | 1.2 | 0.8 | 0.5 |
| Primary sclerosing cholangitis | 2.4 | 2.6 | -0.08 |
| Psoriasis | 3.8 | 3.4 | 0.12 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 8.2 | 4.1 | 1 |
| Rosacea | 1.2 | 1 | 0.2 |
| Schizophrenia | 6 | 3.1 | 0.94 |
| scoliosis | 0.9 | 0.7 | 0.29 |
| Sjögren syndrome | 2.9 | 2.7 | 0.07 |
| Sleep Apnea | 1.9 | 1.8 | 0.06 |
| Slow gastric motility / Gastroparesis | 1.5 | 0.3 | 4 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 2.7 | 0.5 | 4.4 |
| Stress / posttraumatic stress disorder | 3.2 | 2.2 | 0.45 |
| Systemic Lupus Erythematosus | 4.1 | 1.9 | 1.16 |
| Tic Disorder | 0.9 | 1.8 | -1 |
| Tourette syndrome | 0.9 | 0.3 | 2 |
| Type 1 Diabetes | 3.6 | 3.6 | 0 |
| Type 2 Diabetes | 8.1 | 6.8 | 0.19 |
| Ulcerative colitis | 5 | 5.8 | -0.16 |
| Unhealthy Ageing | 4.5 | 2.4 | 0.88 |
| Vitiligo | 2.1 | 1.5 | 0.4 |
